Dr. Meneghini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Corporate Drive; Mailstop 55B-B2-227
Bridgewater, NJ 08807
Education & Training
- University of Miami/Jackson Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2003
- University of MiamiMBA, Health Administration, 1999 - 2000
- University of Miami School of LawMBA, Health Care Management, 1999 - 2000
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1991
- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1988 - 1989
- Emory University School of MedicineClass of 1988
- Emory UniversityBA, Chemistry and French, 1980 - 1984
Certifications & Licensure
- TX State Medical License 2014 - 2026
- FL State Medical License 1990 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- The Leading Physicians of the World International Association of Healthcare Professionals, 2013
- Who’s Who in America Marquis, 2013
- Top Doctors:South Florida Castle Connolly, 2012
- Join now to see all
Publications & Presentations
PubMed
- 466 citationsInsulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyMark Peyrot, Anthony H. Barnett, Luigi F. Meneghini, P. M. Schumm-Draeger
Diabetic Medicine. 2012-05-01 - 114 citationsFactors associated with injection omission/non‐adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy studyMark Peyrot, Anthony H. Barnett, Luigi F. Meneghini, P. M. Schumm-Draeger
Diabetes, Obesity & Metabolism. 2012-12-01 - 51 citationsBarriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical RealitiesMeryl Brod, Suzanne Alolga, Luigi F. Meneghini
The Patient. 2014-06-24
Journal Articles
- Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths Misconceptions and Clinical RealitiesBrod M, Alolga SL, Meneghini L, The Patient, 6/1/2014
- SOLVE Study Group Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents (OHAs) in routine clinical practiceRoss S, Dzida G, Ji Q, Kaiser M, Ligthelm R, Meneghini L, Nazeri A, Orozco-Beltran D, Pan C, Svendsen AL, J Diabetes, 5/1/2014
- A patient-level analysis of efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine added to oral antidiabetes agents in people with ty...DeVries H, Meneghini L, Barnett AH, Reid T, Dain MP, Landgraf W, Vlajnic A, Traylor L, Bergenstal RM, European Endocrinology, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine in patients with type 2 diabetes and a BMI >30 kg/m2: a meta-analysis of five randomised tr...Philis-Tsimikas A, Rodbard HW, Meneghini LF, Kapur K, Endahl L, Russell-Jones DL, World Diabetes Congress, 12/1/2013
- Lower within-subject variability in mean blood glucose concentration with insulin degludec vs. in-sulin glargine: a meta-analysis of patients with T2DMeneghini L, Harris S, Evans M, Rasmussen S, Johansen T, Pieber T, World Diabetes Congress, 12/1/2013
- Reduced Risk of Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes and a BMI >30 kg/m(2): A Meta-analysis of 5 Randomized TrialsRodbard HW1, Meneghini LF, Russell-Jones DL, Kapur R, Endahl L, Kapor J, Philis-Tsimikas A, Can J Diabetes, 10/1/2013
- Join now to see all
Lectures
- Inpatient management of diabetes12/1/2013
- Ultra-Long Acting Basal Insulin Analogs: Challenges & Opportunities11/1/2013
- Advances in GLP1 Therapy: Current Agents and Combinations11/1/2013
- Join now to see all
Other
- Update on the use of detemir insulin in the management of type 2 diabetesMeneghini LF, Sheik A, US Endocrinology
1/1/2008 - Managing Type 2 Diabetes in Ethnic Minority PopulationsKahn K, Meneghini L, Clinical Medicine Today: Diabetes Newsletter
1/1/2008 - Current Treatment Options for a Type 2 Diabetes Patient Not Controlled on OADsMeneghini LF, Pri-Med Online
http://www.pri-med.com
1/1/2008 - Join now to see all
Press Mentions
- Funeral Service for Capt. Robert Michael Hamaty, ODJuly 10th, 2020
- New Customers and Partnerships Contribute ToJanuary 24th, 2019
- Early Insulin: Better First Treatment for Type 2?October 23rd, 2015
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish, French, Italian
External Links
- Diabetes Research Institutehttp://www.diabetesresearch.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: